ASM International NV ASM.AS
Composite 62/100; the shares have moved about 51% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 23/100 — a strong mark against it.
Balance-sheet strength ranks 90/100 — a strong point in its favour. Quality ranks 80/100 — a strong point in its favour. Growth ranks 64/100 — a moderate point in its favour.
Valuation ranks 23/100 — a strong mark against it. Income ranks 38/100 — a moderate mark against it.
What the company does ASM International NV supplies wafer-processing equipment and materials to semiconductor manufacturers, including ALD, epitaxy, PECVD, and SiC Epi tools. Its products enable surface modification and device layering in chip fabrication.
Key financials ASM reports strong profitability with ROE 25%, ROA 11%, and net margin 31%. Revenue grew 3% YoY while EPS fell -26%, with gross margin 52% and operating margin 32%. Debt/equity is 0.02 and current ratio 2.17.
Stock health Momentum is mixed: -13% over 3m, +3% over 6m, and +74% over 12m. RSI(14) is 28, indicating oversold conditions. The stock is -34% below its 52-week high.
Price vs fair value ASM trades at a PREMIUM of 71.20% to our fair-value estimate of 207.19 and a discount of 46.32% to the 12-month target of 1053.47. - Recent earnings call highlighted record revenue and strong growth (GuruFocus.com) - WSJ reported shares slumped after guidance underwhelmed (The Wall Street Journal) - Investing.com noted ASM beat its own Q2 revenue guidance (Investing.com) - WSJ cited ASM lifting sales outlook as AI fuels orders (The Wall Street Journal)
Looking forward Forward P/E of 40x reflects high expectations for AI-driven demand. Analysts see potential upside to 1053.47, but current valuation remains rich relative to fundamentals. Growth score of 36.1 suggests execution risk.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.